Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 47 (RPL21P47)

Target
RPL21P47
Molecular classification
Other (pseudogene; not a functional molecular family), Related to ribosomal protein L21 family (by sequence homology only)
01

Overview

Ribosomal protein L21 pseudogene 47 (RPL21P47) is a non-functional, processed genomic sequence sharing similarity to the ribosomal protein L21 gene but does not encode a protein or have known biological or therapeutic roles. Pseudogenes like RPL21P47 are commonly found throughout the genome as remnants of gene duplication or retrotransposition events; they generally lack promoter activity, do not produce functional proteins, and are not relevant as therapeutic targets or biomarkers[4][6]. Information on related functional genes, such as RPL21, should not be conflated with the pseudogene itself. If searching for a functional ribosomal protein target, refer instead to "Ribosomal protein L21" (RPL21), which is a structural component of the 60S ribosomal subunit with roles in protein synthesis and disease[1][3][5][7]. However, RPL21P47 is not functionally equivalent to RPL21, nor is it known to be expressed or to have phenotypic effects.

Other names
RPL21_16_486RPL21P47
02

Mechanism of action

None (no known mechanism for drugs or biological effectors)

03

Biological functions

None (pseudogenes generally lack biological functions)No evidence for a biological function for RPL21P47
04

Disease associations

None (no established disease association for this pseudogene)No evidence linking RPL21P47 to any pathology

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 47 (RPL21P47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 47 (RPL21P47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call